Inherently targeted estradiol-derived carbon dots for selective killing of ER (+) breast cancer cells via oridonin-triggered p53 pathway activation

被引:0
|
作者
Khan, Aftab Hossain [1 ]
Basak, Ambalika [1 ]
Zaman, Afreen [1 ]
Das, Prasanta Kumar [1 ]
机构
[1] Indian Assoc Cultivat Sci, Sch Biol Sci, Kolkata 700032, India
关键词
QUANTUM DOTS; NANOPARTICLES; DELIVERY; DOXORUBICIN; ARREST; INHIBITION; RECEPTOR; RELEASE;
D O I
10.1039/d4tb01415d
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
One of the most prevalent cancers globally is breast cancer and approximately two thirds of the breast cancers are hormone receptor positive with estrogen receptors (ER) being a prominent target. Notably, p53 that controls several cellular functions and prevents tumor formation, gets suppressed in breast cancers. Reactivation of p53 can lead to cell cycle arrest as well as apoptosis. Therefore, targeting the estrogen receptor for selective delivery of anticancer drugs that can reactivate p53 in ER (+) breast cancers can be a crucial method in breast cancer therapy. Herein, we have designed and developed estradiol-derived inherently targeted specific carbon dots (E-2-CA-CD) from 17 beta-estradiol and citric acid following a solvothermal method. The synthesized carbon dots were characterized using spectroscopic and microscopic techniques. The water soluble, intrinsically fluorescent E-2-CA-CD showed excellent biocompatibility in MCF-7, MDA-MB-231 as well as NIH3T3 cells and demonstrated target specific bioimaging in ER (+) MCF-7 cells due to the overexpressed ER receptors. Furthermore, oridonin, a well-known hydrophobic anticancer drug capable of upregulating the p53 pathway, was loaded on the carbon dots to increase its bioavailability. E-2-CA-CD-Ori caused similar to 2.2 times higher killing in ER (+) MCF-7 cells compared to ER (-) MDA-MB-231 cells and normal cells NIH3T3. Also, E-2-CA-CD-Ori showed similar to 3 fold better killing in MCF-7 cells compared to native oridonin. E-2-CA-CD-Ori-induced killing of MCF-7 cells took place through the early to late apoptotic pathway along with the elevation of the intracellular ROS level. Importantly, E-2-CA-CD-Ori triggered the activation of the p53 pathway in MCF-7 cells, which in turn induced apoptosis involving the upregulation of Bax and downregulation of Bcl-2 leading to the selective and efficient killing of ER (+) MCF-7 cells.
引用
收藏
页码:11708 / 11720
页数:13
相关论文
共 50 条
  • [21] Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation
    Gu, Guowei
    Barone, Ines
    Gelsomino, Luca
    Giordano, Cinzia
    Bonofiglio, Daniela
    Statti, Giancarlo
    Menichini, Francesco
    Catalano, Stefania
    Ando, Sebastiano
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (10) : 3363 - 3372
  • [22] Overexpression of SMAR1 Enhances Radiosensitivity in Human Breast Cancer Cell Line MCF7 via Activation of p53 Signaling Pathway
    Liu, Heng-chao
    Ma, Fang
    Shen, Yong
    Hu, Yong-quan
    Pan, Shaojun
    ONCOLOGY RESEARCH, 2015, 22 (5-6) : 293 - 300
  • [23] SiRNA-mediated Apollon gene silencing induces apoptosis in breast cancer cells via p53 stabilization and caspase-3 activation
    Pennati, M.
    Lopergolo, A.
    Gandellini, P.
    Folini, M.
    Daidone, M. G.
    Zaffaroni, N.
    EJC SUPPLEMENTS, 2008, 6 (12): : 84 - 84
  • [24] Patient-derived HER3 mutations transform ER+ and HER2+breast cancer cells via MAPK pathway activation
    Mishra, Rosalin
    Alanazi, Samar
    Yuan, Long
    Solomon, Thomas
    Thaker, Tarjani M.
    Jura, Natalia
    Garrett, Joan T.
    CANCER RESEARCH, 2018, 78 (13)
  • [25] p53 pathway restoring small molecule Prodigiosin targets chemotherapy-resistant colorectal cancer stem cells in vitro and in vivo via p73 activation
    Prabhu, Varun Vijay
    Hong, Bo
    Allen, Joshua E.
    Zhang, Shengliang
    Dicker, David T.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2014, 74 (19)
  • [26] Activation of Esterase D by FPD5 Inhibits Growth of A549 Lung Cancer Cells via JAB1/p53 Pathway
    Yao, Wen
    Yang, Yuejun
    Chen, Xinpeng
    Cui, Xiaoling
    Zhou, Bangzhao
    Zhao, Baoxiang
    Lin, Zhaomin
    Miao, Junying
    GENES, 2022, 13 (05)
  • [27] Induction of Apoptosis and Cell-Cycle Arrest in Human Colon-Cancer Cells by Whole-Grain Alkylresorcinols via Activation of the p53 Pathway
    Fu, Junsheng
    Soroka, Dominique N.
    Zhu, Yingdong
    Sang, Shengmin
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2018, 66 (45) : 11935 - 11942
  • [28] Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer
    Chen, Miaomiao
    Zhang, Hongqin
    Zhang, Guihong
    Zhong, Ailing
    Ma, Qian
    Kai, Jinyan
    Tong, Yin
    Xie, Suhong
    Wang, Yanchun
    Zheng, Hui
    Guo, Lin
    Lu, Renquan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 507 (1-4) : 74 - 82
  • [29] Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells
    Moh, Mei Chung
    Zhang, Ting
    Lee, Lay Hoon
    Shen, Shali
    CARCINOGENESIS, 2008, 29 (12) : 2298 - 2305
  • [30] Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-κB p65 to evoke reactive oxygen species generation and p53 activation
    M Yin
    X Ren
    X Zhang
    Y Luo
    G Wang
    K Huang
    S Feng
    X Bao
    K Huang
    X He
    P Liang
    Z Wang
    H Tang
    J He
    B Zhang
    Oncogene, 2015, 34 : 691 - 703